Table 2.

Outcomes of patients who received neoadjuvant therapy prior to pancreaticoduodenectomy

	50.4Gy (n = 221)	30Gy (n = 224)	p-Value*	No XRT (n = 27)	p-Value#
Locoregional Recurrence, n (%)	48 (21.7)	49 (21.9)	0.73	9 (33.3)	<0.01
Any Recurrence			0.54		<0.05
Recurrence-Free Survival, Months, Median	14.7	16.0		9.9
5-year Recurrence-Free Survival	28.1%	31.4%		14.2%
Overall Survival			0.41		0.33
Overall Survival, Months, Median	38.2	33.7		28.4
5-year Overall Survival	36.1%	28.9%		27.2%
Follow-up, Months, Mean (StDev)	36.3 (23.1)	49.1 (45.0)	<0.001	30.8 (20.9)	0.08

^*p-Values compare 30Gy vs 50.4Gy;

^#p-Values compare XRT (30Gy or 50.4Gy) vs No XRT